| Systematic review and meta‐analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease M Jamalinia, F Zare, KB Lankarani Alimentary Pharmacology & Therapeutics 58 (4), 384-394, 2023 | 21 | 2023 |
| Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease M Jamalinia, F Zare, K Noorizadeh, K Bagheri Lankarani Alimentary Pharmacology & Therapeutics 59 (4), 445-458, 2024 | 9 | 2024 |
| Sex and gender differences in liver fibrosis: pathomechanisms and clinical outcomes M Jamalinia, A Lonardo, R Weiskirchen Fibrosis 2 (4), 10006, 2024 | 4 | 2024 |
| Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge M Jamalinia, A Lonardo Metabolism and Target Organ Damage 4 (3), 23, 2024 | 4 | 2024 |
| Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification K Bagheri Lankarani, M Jamalinia, F Zare, ST Heydari, A Ardekani, ... Advances in Therapy, 1-16, 2025 | | 2025 |
| Association of liver fibrosis with aneurysm size and mortality risk in patients undergoing open abdominal aortic aneurysm repair M Jamalinia, SA Mirhosseini, M Ranjbar, K Bagheri Lankarani, ... Scientific Reports 15 (1), 3301, 2025 | | 2025 |
| MASLD: predictive value for liver-related events and extra-hepatic complications M Jamalinia, A Lonardo Expert Review of Gastroenterology & Hepatology 18 (11), 685-688, 2024 | | 2024 |
Kamran B LankaraniDistinguished Professor of Internal Medicine, HPRC,Shiraz University of Medical SciencesEmail verificata su sums.ac.ir